5 Best Biotech Stocks To Buy According To Hedge Funds

2. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Investors In Q1 2023: 75

Merck & Co., Inc. (NYSE:MRK) is a healthcare company headquartered in Rahway, New Jersey. The firm provides products and testing services to the biotechnology and biopharmaceutical industries. It has also invested in biotechnology development facilities.

75 of the 943 hedge funds part of Insider Monkey’s database had held a stake in Merck & Co., Inc. (NYSE:MRK) during Q1 2023. Out of. these, the firm’s largest shareholder is Ken Fisher’s Fisher Asset Management with a $1.3 billion investment.

Follow Merck & Co. Inc. (NYSE:MRK)